Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
GATX CORP incurred senior notes of $400,000,000 aggregate principal amount with BofA Securities, Inc., Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC at 6.900% maturing 2034.
- Instrument
- senior notes
- Principal
- $400,000,000 aggregate principal amount
- Counterparty
- BofA Securities, Inc., Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC
- Rate
- 6.900%
- Maturity
- 2034
- Event
- incurrence
Exact text from the filing
GATX agreed to sell and the Underwriters agreed to purchase, subject to and upon terms and conditions set forth therein, $400,000,000 aggregate principal amount of 6.900% Senior Notes due 2034
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
GATX CORP entered into Underwriting Agreement with BofA Securities, Inc., Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC valued at $400,000,000 aggregate principal amount of 6.900% Senior Notes due 2034 (effective 2023-10-31).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- BofA Securities, Inc., Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC
- Value
- $400,000,000 aggregate principal amount of 6.900% Senior Notes due 2034
- Effective
- 2023-10-31
Exact text from the filing
GATX Corporation (“GATX”) entered into an Underwriting Agreement (the “Underwriting Agreement”), with BofA Securities, Inc., Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC, as representatives of the several underwriters listed therein (collectively, the “Underwriters”), dated October 31, 2023, pursuant to which GATX agreed to sell and the Underwriters agreed to purchase, subject to and upon terms and conditions set forth therein, $400,000,000 aggregate principal amount of 6.900% Senior Notes due 2034 (the “Notes”), as described in the prospectus supplement, dated October 31, 2023 (the “Prospectus Supplement”), filed pursuant to GATX’s shelf registration statement on Form S-3, Registration No. 333-264721.
View on SEC.gov